If Uplizna (Inebilizumab) Isn't Approved by Cigna in Virginia: Formulary Alternatives & Exception Paths
Answer Box: When Cigna Denies Uplizna (Inebilizumab) in Virginia
If Cigna denies Uplizna (inebilizumab) for NMOSD or IgG4-related disease in Virginia, you have three main paths: (1) try formulary alternatives like Enspryng or Soliris first (step therapy), (2) request a formulary exception with medical necessity documentation, or (3) appeal through